3rd Quarter - Report

THE NICKLES GROUP, LLC for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Monitored H.R. 4378, the Continuing Appropriations Act of 2020, and Health Extenders Act of 2019.

LobbyistCovered position, as disclosed
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 4378 (116th)

Taxation/Internal Revenue Code TAX

Monitor implementation of The Tax Cut and Jobs Act as it relates to corporate tax reform and the taxation of U.S. multinational corporations. S. 692, Protect Medical Innovation Act of 2019 and H.R. 3301, Taxpayer Certainty and Disaster Tax Relief Act of 2019, as they relate to the medical device tax.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —
EMILY PORTER —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Bills named: S. 692 (116th), H.R. 3301 (116th)

Medicare/Medicaid MMM

Issues related to ESRD PPS and innovative device reimbursement policies. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Issues regarding dialysis in the home.

LobbyistCovered position, as disclosed
EMILY PORTER —
KATHERINE RAAB —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2710 (116th)

Health Issues HCR

Monitored issues related to pharmaceutical prices. Issues related to ESRD payment. H.R. 2710, Patient Access to ESRD New Innovative Devices Act. Monitored H.R. 2296, METRIC Act of 2019. S. 1895, Lower Health Care Costs Act of 2019; S. 2593, Prescription Drug Pricing Reduction Act of 2019; Issues involving drug shortages. Issues regarding the Strategic National Stockpile inventory. Issues related to home dialysis.

LobbyistCovered position, as disclosed
EMILY PORTER —
KATHERINE RAAB —
MARY BETH SAVARY TAYLOR —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 2593 (116th), H.R. 2296 (116th), H.R. 2710 (116th), S. 1895 (116th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.